NeoGenomics Laboratories launched PTEN IHC CDx as part of PanTracer Pro, pairing IHC-based PTEN deficiency identification with comprehensive genomic profiling.
Public source
Publisher name
Public post
PTEN IHC CDx is now available as part of PanTracer Pro, pairing IHC-based PTEN deficiency identification with comprehensive genomic profiling for a more complete biomark…
Company
NeoGenomics Laboratories
Answers are in our DNA™
- Industry
- Hospitals and Health Care
- Location
- Fort Myers, US
- Company size
- 1,001–5,000 employees
About NeoGenomics Laboratories
Our vision: A world where every cancer treatment decision is as personal as the patient. Our mission: We take cancer personally. We partner with physicians to deliver actionable insights that guide personalized treatment decisions and improve outcomes -- through a comprehensive oncology portfolio and an unwavering commitment to excellence powered by a team of dedicated experts.
See moreLatest activity
Latest activity from NeoGenomics Laboratories
9 signals
Products & Services
NeoGenomics Laboratories launched Neo Comprehensive® for Myeloid Disorders testing, offering a single test for DNA and RNA alterations in a complete genomic view.
Presence & Recognition
NeoGenomics Laboratories presented research on AI-based detection and scoring of TROP2 expression in IHC-stained NSCLC specimens at AACR 2026, along with AI applications for automated phenotyping of multiplex immunofluorescence data.
People
NeoGenomics Laboratories is hiring two positions for the Product Marketing Team: one as a Director leading strategy across the portfolio and another as a Marketing Manager owning MRD in oncology.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
GoPath Diagnostics
GoPath Diagnostics launched ProstateNow, a germline test for prostate cancer combining multi-gene analysis with a risk-focused approach to support real-world decision-making.
Products & Services
EMQN CIC
EMQN CIC launched a new Haemato-Oncology EQA category for the 2027 EQA Catalogue.
Products & Services
Labcorp
Labcorp launched the Marker by Labcorp Genetic Health Panel to help make personalized genetic insights more accessible through an easy-to-use experience.
Products & Services
Caris Life Sciences
Caris Life Sciences launched MI Cancer Seek, the first and only simultaneous Whole Exome Sequencing and Whole Transcriptome Sequencing based assay with FDA-approved CDx indications, designed for adult and pediatric patients aged 1+
Products & Services
Myriad Genetics